Related Experiment Video
Updated: May 17, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Rhinocerebral mucormycosis: A deadly disease on the rise
R S Mane1, J K Watve, A A Mohite
1Dept. of ENT, Dr. D.Y. Patil Medical College Hospital, Kadamwadi Kolhapur, India.
Abstract:
According to WHO, there will be epidemic of diabetes world over and India is going to be 'A diabetes capital of the world' by 2025. With the increasing incidence of diabetes, the associated complications are also bound to increase. Rhinocerebral mucormycosis is one of them.Rhinocerebral Mucormycosis is an opportunistic, fulminating fungal infection, caused by Rhizopus species of order of mucorales, frequently seen in diabetic and immunocompromised patients. Mucormycosis has a very high mortality rate.Early diagnosis and treatment with Amphotericin-B is the key to combat this disease successfully. We have seen 13 cases in last 3 years (2002-2005) in our area. This incidence is significant, as this type of cases were rarely seen before 2002, in this geographical area. We present an account of these cases; treatment strategies adopted, review of literature, and highlight 'the role of ENT surgeon in diagnosis and management of this dreadful disease'.
Insights
India faces a diabetes epidemic, increasing risks of complications like Rhinocerebral Mucormycosis. Early diagnosis and Amphotericin-B treatment are crucial for managing this severe fungal infection in diabetic patients.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Otolaryngology
Background:
- Diabetes mellitus is a growing global health concern, with India projected as the 'diabetes capital'.
- This rise in diabetes incidence correlates with an increase in associated opportunistic infections, such as Rhinocerebral Mucormycosis.
- Rhinocerebral Mucormycosis, a severe fungal infection caused by Rhizopus species, poses a significant mortality risk, particularly in immunocompromised individuals.
Purpose of the Study:
- To report a significant increase in Rhinocerebral Mucormycosis cases in a specific geographical area between 2002 and 2005.
- To detail the treatment strategies employed for these cases.
- To review existing literature and emphasize the critical role of Ear, Nose, and Throat (ENT) surgeons in the diagnosis and management of this infection.
Main Methods:
- Retrospective case series analysis of 13 patients diagnosed with Rhinocerebral Mucormycosis from 2002 to 2005.
- Review of medical records, treatment protocols, and patient outcomes.
- Literature review on Rhinocerebral Mucormycosis epidemiology, diagnosis, and management.
Main Results:
- A notable increase in Rhinocerebral Mucormycosis incidence was observed in the study area, with 13 cases reported over three years, a rate significantly higher than previously recorded.
- The study highlights the effectiveness of early diagnosis and treatment with Amphotericin-B in managing the infection.
- The crucial role of ENT surgeons in the timely identification and surgical management of Rhinocerebral Mucormycosis was underscored.
Conclusions:
- The rising prevalence of diabetes in India is associated with an increased incidence of opportunistic infections like Rhinocerebral Mucormycosis.
- Prompt diagnosis and aggressive treatment, including antifungal therapy and surgical intervention by ENT specialists, are vital for improving patient outcomes and reducing mortality.
- Increased awareness and proactive management strategies are necessary to combat the growing threat of Rhinocerebral Mucormycosis in diabetic populations.
Related Concept Videos
Fungal Group Zygomycota
Bacterial Meningitis I: Introduction
Fungal Phylum Basidiomycota
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Bacterial Meningitis II: Pathophysiology
Fungal Phylum Microsporidia
